28-Jun-16 Pfizer Inc will invest USD350 mn to build a biotech center in China, the latest in move by pharma industry giants to set up in the world's no.2 drugs market, with the aim of securing faster approvals for products. The facility in Hangzhou - Pfizer's first biotech center in Asia - is expected to be completed by 2018. [image: Reuters / Andrew Kelly]

09-Jun-16 Basic healthcare is becoming less accessible to ordinary Russians. Medicine sales have fallen for the first time in Russia since 2008: Analysts recorded a 10% drop in drug sales in the first quarter of 2016. During a severe economic crisis, a growing number of Russians can no longer afford to buy medicine. [image: Andrei Iglov / RIA Novosti]

31-May-16 Singapore-based Imagene Labs and New York-based LifeNome Inc have announced a partnership to bring genomic personalization to Southeast Asia. The partnership will leverage on the genetics testing facilities of Imagene Labs together with the proprietary bioinformatics platform of LifeNome, to provide consumers in the region with personalized guidance on nutrition, fitness, skincare and other wellness topics. [image: Pulse / LinkedIn]

25-May-16 Sanofi will step up its push into China, its second biggest market after the United States, in the next five years as part of a wider expansion into emerging countries, where it sees a large part of its future growth. [image: Reuters / Robert Pratta]

21-May-16 Developing traditional medicine in combination with modern healthcare is the top priority of the Vietnamese Party, State and the Ministry of Health. Health Minister Nguyen Thi Kim Tien delivered the message at a teleconference to review the five-year implementation of Vietnam’s traditional medicine development plan by 2020. [image: VNA]